These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 24171783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Part 2: MRI of hypervascular focal liver lesions using liver specific contrast agents.
    Sutherland T, Seale M, Yap K.
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):56-63. PubMed ID: 24529056
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF.
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS.
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver.
    Asbach P, Klessen C, Koch M, Hamm B, Taupitz M.
    Clin Imaging; 2007 Jul; 31(4):244-52. PubMed ID: 17599618
    [Abstract] [Full Text] [Related]

  • 6. Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics.
    Grieser C, Steffen IG, Seehofer D, Kramme IB, Uktolseya R, Scheurig-Muenkler C, Hamm B, Denecke T.
    Magn Reson Imaging; 2013 Jun; 31(5):755-60. PubMed ID: 23219272
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC.
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA, Pedro MT, Ruivo C, Semedo LC, Marques C, Alves FC.
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [Abstract] [Full Text] [Related]

  • 11. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA.
    Radiographics; 2004 Dec; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC.
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [Abstract] [Full Text] [Related]

  • 13. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
    Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S.
    Radiology; 2012 Feb; 262(2):520-9. PubMed ID: 22282184
    [Abstract] [Full Text] [Related]

  • 14. Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.
    Alberti N, Frulio N, Bioulac-Sage P, Laumonier H, Balabaud C, Perez JT, Teixeira FR, Harbonnier N, Trillaud H.
    Diagn Interv Imaging; 2014 Jan; 95(1):77-83. PubMed ID: 24139183
    [Abstract] [Full Text] [Related]

  • 15. Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.
    Fujiwara H, Sekine S, Onaya H, Shimada K, Mikata R, Arai Y.
    Jpn J Radiol; 2011 Dec; 29(10):739-43. PubMed ID: 22009428
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW.
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [Abstract] [Full Text] [Related]

  • 17. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
    Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E, Azoulay D, Mallat A, Rahmouni A, Luciani A.
    Abdom Radiol (NY); 2017 Mar; 42(3):825-832. PubMed ID: 27704147
    [Abstract] [Full Text] [Related]

  • 18. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
    Burke C, Alexander Grant L, Goh V, Griffin N.
    Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
    [Abstract] [Full Text] [Related]

  • 19. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.
    Karam AR, Shankar S, Surapaneni P, Kim YH, Hussain S.
    J Magn Reson Imaging; 2010 Aug; 32(2):341-4. PubMed ID: 20677260
    [Abstract] [Full Text] [Related]

  • 20. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI.
    Finley AC, Hosey JR, Noone TC, Shackelford DM, Varadarajulu S.
    Magn Reson Imaging; 2005 Apr; 23(3):511-3. PubMed ID: 15862653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.